Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
about
Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathwayA new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.CCAAT enhancer-binding protein alpha is a molecular target of 1,25-dihydroxyvitamin D3 in MCF-7 breast cancer cells.Anticancer activities of artemisinin and its bioactive derivatives.E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.
P2860
Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tamoxifen induction of CCAAT e ...... r tamoxifen-induced apoptosis.
@en
type
label
Tamoxifen induction of CCAAT e ...... r tamoxifen-induced apoptosis.
@en
prefLabel
Tamoxifen induction of CCAAT e ...... r tamoxifen-induced apoptosis.
@en
P2093
P2860
P356
P1476
Tamoxifen induction of CCAAT e ...... r tamoxifen-induced apoptosis.
@en
P2093
David J Shapiro
David V Yu
Jian-Hua Zhou
Jingwei Cheng
P2860
P304
30535-30543
P356
10.1074/JBC.M704829200
P407
P577
2007-08-23T00:00:00Z